Skip to content
Subscriber Only

Genetic Test Helps Identify Aggressive Prostate Cancer

A novel test from Genomic Health Inc. helps predict whether prostate cancer is aggressive or slow-growing, giving patients and doctors more information to shape treatment for the most common tumor found in men, a study found.

Results from the study presented today at the American Urological Association meeting in San Diego may triple the number of men whose cancer can be closely monitored for growth rather than vigorously targeted for destruction, the Redwood City, California-based company said in a statement. The research in 395 men found the Oncotype DX Genomic Prostate Score provided meaningful detail on which tumors were likely to spread.